Online Exclusive

Online Exclusive

Proposed Budget Would Cut Cancer and Biomedical Research Funding

Tuesday, March 28th, 2017
The Trump administration’s proposed budget for 2018 includes nearly $6 billion in budget cuts to the National Institutes of Health (NIH) – an approximate...

MSC-100-IV Receives Fast-Track Designation

Monday, March 27th, 2017
The U.S. Food and Drug Administration has granted fast-track designation for MSC-100-IV for pediatric patients with steroid-refractory acute graft-versus-host disease (aGVHD) following allogeneic hematopoietic...

Mortality Rates in Childhood Cancer Higher Than Previously Thought

Friday, March 24th, 2017
Early death among young children (<1 year of age) with cancer is higher than previous estimates according to a study published in the Journal...

First-Year Residents Can Work 24-Hour Shifts Again

Thursday, March 23rd, 2017
Starting on July 1, 2017, first-year residents will again be permitted to work shifts as long as 24 hours, per a memo from the...

Is Generic Imatinib as Effective as Branded Imatinib for CML?

Wednesday, March 22nd, 2017
In a comparison of generic and branded imatinib as first-line and second-line treatment of chronic myeloid leukemia (CML), researchers found that generic imatinib may...

A Radiation-Free Regimen for Patients With Fanconi Anemia and Related Conditions?

Wednesday, March 22nd, 2017
Authors’ Perspective Lead author Parinda Mehta, MD, and senior author Farid Boulad, MD: “Our results show a clear and critical need for improvement in outcomes...

Financial Toxicity Forces Cancer Patients to Change Prescription Drug Use

Tuesday, March 21st, 2017
Adults with a cancer diagnosis were more likely to change their prescription drug use for financial reasons than patients without a history of cancer,...

Brentuximab Vedotin “Unexpectedly” Ineffective in Patients With Primary Mediastinal B-Cell Lymphoma

Monday, March 20th, 2017
Author’s Perspective Lead author Pier Luigi Zinzani, MD: “This low response rate of brentuximab vedotin (BV) in primary mediastinal B-cell lymphoma was an  unexpected finding...

MedPAC Considers Restructuring Medicare Part B

Monday, March 20th, 2017
The Medicare Payment Advisory Commission (MedPAC) released a draft package proposing several changes to Medicare’s Part B program, which regulates how doctors are paid...

New Drug Prevents CMV Infection in Transplant Patients

Friday, March 17th, 2017
In an international phase III clinical trial, the novel antiviral agent letermovir was shown to lower patients’ risk of developing cytomegalovirus (CMV) infection following...
Advertisement

Current Issue

April 2017, Volume 3, Issue 5

This issue examines the art and science of myeloma drug sequencing, Mikkael Sekeres' letter to the ABIM, highlights from the 16th International Myeloma Workshop, and more.